Gene therapy success raises hopes of 'cure' for HIV
Doctors say engineering an HIV patient's own immune cells could eliminate the need for daily antiretroviral drugs
DOCTORS have used gene therapy to modify the immune systems of 12 patients to help "shield" them from the effects of HIV, the BBC reports.
The new treatment could replace programmes that require HIV patients to take antiretroviral medication every day.
In a study published in the New England Journal of Medicine on Wednesday, scientists said that by creating beneficial mutations in T-cells they might have found a new therapy for improving the health of people with HIV.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Some patients have a rare mutation in their T-cells, white blood cells that are vital to human immune responses, that prevents the virus from getting inside and multiplying.
Doctors working on the study reported that patients receiving their genome-modifying treatment had "decreased viral loads". In one patient who had received the treatment the virus could no longer be detected at all.
Out of the 12 people who took part in the test, six stopped taking their antiretroviral medication so that researchers could assess the effects of the genome-modifying treatment. In four of those patients, the amount of HIV in the blood dropped. And in one patient, the virus could "no longer be detected at all", according to a Massachusetts Institute of Technology (MIT) report.
Doctors stressed that the study was only intended to determine the safety of the treatment, rather than determining whether "HIV shielding" could be a feasible replacement for drug treatment.
"We are absolutely encouraged by these results," said Bruce Levine the director of the Clinical Cell and Vaccine Production Facility at the University of Pennsylvania. "It is an evolution in the treatment of HIV from daily antiretroviral therapy."
Levine, who ran the study with his colleague Carl June, noted that it was too early to say whether the treatment could come to replace daily antiretroviral drugs, The Guardian reports.
"Cure is a four letter word. We don't like to use it, particularly with HIV. We are looking at improving the health and immune function of people with HIV," Levine said.
Academics cautiously welcomed the findings. In an editorial that sat alongside the report, researchers from Stanford and Harvard Universities, Mark Kay and Bruce Walker, wrote: "The tantalising question... is whether it might actually have been partially effective. A definitive answer to this question will require additional studies."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
4 ways to give back this holiday season
The Explainer If your budget is feeling squeezed, remember that money is not the only way you can be generous around the holidays
By Becca Stanek, The Week US Published
-
4 tips for hosting an ecofriendly Thanksgiving
The Week Recommends Coming together for the holidays typically produces a ton of waste, but with proper preparation, you can have an environmentally friendly gathering.
By Theara Coleman, The Week US Published
-
Jussie Smollet conviction overturned on appeal
Speed Read The Illinois Supreme Court overturned the actor's conviction on charges of staging a racist and homophobic attack against himself in 2019
By Peter Weber, The Week US Published
-
Home Office worker accused of spiking mistress’s drink with abortion drug
Speed Read Darren Burke had failed to convince his girlfriend to terminate pregnancy
By The Week Staff Published
-
In hock to Moscow: exploring Germany’s woeful energy policy
Speed Read Don’t expect Berlin to wean itself off Russian gas any time soon
By The Week Staff Published
-
Were Covid restrictions dropped too soon?
Speed Read ‘Living with Covid’ is already proving problematic – just look at the travel chaos this week
By The Week Staff Last updated
-
Inclusive Britain: a new strategy for tackling racism in the UK
Speed Read Government has revealed action plan setting out 74 steps that ministers will take
By The Week Staff Published
-
Sandy Hook families vs. Remington: a small victory over the gunmakers
Speed Read Last week the families settled a lawsuit for $73m against the manufacturer
By The Week Staff Published
-
Farmers vs. walkers: the battle over ‘Britain’s green and pleasant land’
Speed Read Updated Countryside Code tells farmers: ‘be nice, say hello, share the space’
By The Week Staff Published
-
Motherhood: why are we putting it off?
Speed Read Stats show around 50% of women in England and Wales now don’t have children by 30
By The Week Staff Published
-
Anti-Semitism in America: a case of double standards?
Speed Read Officials were strikingly reluctant to link Texas synagogue attack to anti-Semitism
By The Week Staff Published